Women's Health in Autoimmune Diseases 2020
DOI: 10.1007/978-981-15-0114-2_7
|View full text |Cite
|
Sign up to set email alerts
|

Update on Use of Biologic and Targeted Synthetic Drugs in Pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 58 publications
0
1
0
Order By: Relevance
“…To improve pregnancy outcomes for women with axSpA, RA or PsA, it is imperative to control disease activity using medications compatible with pregnancy 11 13–15. Recommendations regarding use of biologics during pregnancy are inconsistent across major rheumatology organisations and the American College of Gynaecology (ACOG)12 16–19 (online supplemental table S1).…”
Section: Introductionmentioning
confidence: 99%
“…To improve pregnancy outcomes for women with axSpA, RA or PsA, it is imperative to control disease activity using medications compatible with pregnancy 11 13–15. Recommendations regarding use of biologics during pregnancy are inconsistent across major rheumatology organisations and the American College of Gynaecology (ACOG)12 16–19 (online supplemental table S1).…”
Section: Introductionmentioning
confidence: 99%